| 2025-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|
Total money the company brought in from its core business during the period, before any costs are subtracted. | $4.09M | $233000 | $20.38M |
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes. | -$644.06M | -$144.79M | -$135.81M |
Operating income as a percentage of revenue. | -15751.1% | -62140.3% | -666.5% |
The company's bottom-line profit after all expenses, interest, and taxes are subtracted. | -$100000 | -$5.03M | -$6.44M |
Net income divided by the number of shares outstanding — profit attributable to each share. | $-2.91 | $-0.98 | $-1.21 |
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure. | $-2.91 | $-0.98 | – |
| 2025-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|
Cash and highly liquid short-term investments the company can access almost immediately. | $85.30M | $190.60M | $362.30M |
Everything the company owns that has value — cash, property, inventory, investments, and more. | $292.72M | $305.44M | $414.17M |
All of the company's interest-bearing borrowings, short and long term combined. | $0 | – | – |
Everything the company owes — debt, unpaid bills, and other obligations. | $70.72M | $39.67M | $28.21M |
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities. | $221.87M | $260.74M | $376.91M |
| 2025-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items. | -$102.67M | -$104.47M | -$63.25M |
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business. | $901000 | $773000 | $173000 |
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment. | -$103.58M | -$105.24M | -$63.42M |